You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Valmet Q1'24: The glass is half full
Our analyst Antti Viljakainen comments on Valmet's Q1 and our valuation and recommendation for the company at the moment!
Content:
00:00 Intro
00:11 Why was Valmet's Q1 neutral in our view
01:39 Differences between segments
03:02 Drop in order intake
03:42 Order intake's conversion to revenue
04:56 Valuation and recommendation
Read the latest research report:
The Glass is half full , published 2024-05-06
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
View all videos